![]() 108090000623 proteins and genes Proteins 0.000 claims description 295.102000004169 proteins and genes Human genes 0.000 claims description 295.230000004952 protein activity Effects 0.000 claims abstract description 21.239000002157 polynucleotides Substances 0.000 claims abstract description 114.229920000023 polynucleotides Polymers 0.000 claims abstract description 114.230000000694 effects Effects 0.000 title claims description 88.230000001580 bacterial Effects 0.000 title claims abstract description 58.230000002829 reduced Effects 0.000 title claims abstract description 75. ![]() Application granted granted Critical Publication of US9493559B2 publication Critical patent/US9493559B2/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). ![]() Assignors: ELLIS, MARK, HUMPHREYS, DAVID PAUL Assigned to UCB PHARMA, S.A. ![]() Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to GB1000591.6 priority Critical Priority to GBGB1000591.6A priority patent/GB201000591D0/en Priority to PCT/EP2011/050416 priority patent/WO2011086139A1/en Priority to US201213522083A priority Priority to US14/633,294 priority patent/US9493559B2/en Application filed by UCB Pharma SA filed Critical UCB Pharma SA Publication of US20150166652A1 publication Critical patent/US20150166652A1/en Assigned to CELLTECH R&D LTD. Original Assignee UCB Pharma SA Priority date (The priority date is an assumption and is not a legal conclusion. ![]() Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Mark Ellis David Paul Humphreys Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US14/633,294 Other versions US9493559B2 Google Patents US20150166652A1 - Bacterial host strain expressing recombinant dsbc and having reduced tsp activity US20150166652A1 - Bacterial host strain expressing recombinant dsbc and having reduced tsp activity ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |